Brief: Lombard Medical reports Q2 loss per share $0.42

Lombard Medical

22/08/2016 21:00

Aug 22 (Reuters) - Lombard Medical Inc  EVAR.O  
    * Reports 2016 second quarter, six-month financial results 
and provides update on strategic initiatives 
    * Q2 loss per share $0.42 
    * Q2 revenue $3.8 million versus I/B/E/S view $3.8 million 
    * Q2 earnings per share view $-0.40 -- Thomson Reuters 
I/B/E/S 
    * Board of directors has engaged Cain Brothers as its 
investment banker to begin a process of exploring strategic 
alternatives 
    * Exploring strategic alternatives, including a potential 
sale of company or disposition of certain assets 
    * Company will also be evaluating additional financing 
opportunities 
    * Allocating resources to support new Altura AAA stent graft 
system and Intelliflex LP delivery system for Aorfix in European 
Union, Japan and other international markets 
    * Due to suspension of US commercial operation, says  
"prudent" to amend revenue guidance for year to between $13 
million and $15 million 
    * Aorfix sales force in us has been eliminated and majority 
of commercial operations have transitioned to company's facility 
in UK 
 
Source text for Eikon:  ID:nGNXMZZKTa  
Further company coverage:  EVAR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))